Fidelity Investments
CMPX icon

Fidelity Investments’s Compass Therapeutics CMPX Stock Holding History

Fidelity Investments’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.53M Sell
1,801,721
-777,990
-30% -$4.49M ﹤0.01% 2061
2025
Q4 		$13.9M Sell
2,579,711
-1,557,851
-38% -$7.19M ﹤0.01% 1908
2025
Q3 		$14.5M Buy
4,137,562
+2,907
+0.1% +$9.18K ﹤0.01% 1862
2025
Q2 		$10.8M Buy
4,134,655
+368
+0% +$759 ﹤0.01% 1904
2025
Q1 		$7.86M Sell
4,134,287
-2,116
-0.1% -$5.63K ﹤0.01% 2003
2024
Q4 		$6M Buy
4,136,403
+130
+0% +$216 ﹤0.01% 2096
2024
Q3 		$7.61M Buy
4,136,273
+5,898
+0.1% +$7.35K ﹤0.01% 2006
2024
Q2 		$4.13M Sell
4,130,375
-384,762
-9% -$562K ﹤0.01% 2134
2024
Q1 		$8.94M Sell
4,515,137
-36,369
-0.8% -$62.9K ﹤0.01% 1907
2023
Q4 		$7.1M Sell
4,551,506
-1,587
-0% -$2.75K ﹤0.01% 1957
2023
Q3 		$8.97M Sell
4,553,093
-982,413
-18% -$2.43M ﹤0.01% 1853
2023
Q2 		$17.6M Sell
5,535,506
-145,566
-3% -$457K ﹤0.01% 1693
2023
Q1 		$18.6M Sell
5,681,072
-673,742
-11% -$2.65M ﹤0.01% 1634
2022
Q4 		$32M Hold
6,354,814
– – ﹤0.01% 1434
2022
Q3 		$14.5M Sell
6,354,814
-517,600
-8% -$1.43M ﹤0.01% 1742
2022
Q2 		$18.2M Hold
6,872,414
– – ﹤0.01% 1688
2022
Q1 		$9.42M Hold
6,872,414
– – ﹤0.01% 2142
2021
Q4 		$21.8M Buy
+6,872,414
New +$22.8M ﹤0.01% 1781

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments's CMPX Position: Q1 2026 in Review

Fidelity Investments reduced its Compass Therapeutics (CMPX) stake by 30% in Q1 2026, selling an estimated $4.49M and leaving 1,801,721 shares worth $9.53M. The position accounts for ﹤0.01% of the portfolio, ranked #2061.

Fidelity Investments first reported a position in CMPX in Q4 2021 and has held it in 18 quarters since. The position peaked at $32M in Q4 2022. 201 funds tracked by Wall St. Rank hold CMPX as of Q1 2026.

  • Fidelity Investments held 1,801,721 shares of Compass Therapeutics worth $9.53M as of Q1 2026.
  • Fidelity Investments sold 777,990 Compass Therapeutics shares in Q1 2026, an estimated $4.49M.
  • Compass Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #2061 holding.
  • Fidelity Investments first reported a position in Compass Therapeutics in Q4 2021 and has held it in 18 quarters since.
  • Fidelity Investments's Compass Therapeutics position peaked at $32M in Q4 2022.
  • 201 funds tracked by Wall St. Rank held Compass Therapeutics as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.